By using a metabolomic approach, this study explores how the plasma metabolite profile is regulated in response to humanin and SHLP2 treatment in a diet-induced obesity (DIO) mouse model. The gene discussed is MT-RNR2; the disease is obesity due to melanocortin 4 receptor deficiency.